LambdaVision
Farmington
About LambdaVision
LambdaVision is a biotechnology company focused on developing a protein-based artificial retina designed to restore meaningful vision for patients affected by retinal degenerative diseases. The technology uses the light-activated protein bacteriorhodopsin layered alternately with polymers onto a flexible, ion-permeable membrane in a thin-film structure that mimics the function of photoreceptor cells. LambdaVision is also leveraging microgravity manufacturing’via flights to the International Space Station (ISS) and low-Earth orbit (LEO) environments’to enhance the homogeneity, stability, and optical quality of its artificial retina membranes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $13.7M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: lambdavision.com
- Phone: +1 860-679-2558
Industries & Categories
Aerospace, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lambdavision-15917 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.